Clinical trial
Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance
NCT07371169 is registered in ClinicalTrials.gov with Uruk University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance
- Lead sponsor
- Uruk University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2025
- Completion date
- January 1, 2026
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.